
Mitodus 10mg Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Mitomycin (10mg)
Overview Mitodus 10mg Injection
Oncolytic injection Mitodus (10mg) treats specific pancreatic, breast, lung, and gastric cancers. It's administered intravenously by a physician, either solely or as part of combination chemotherapy to inhibit cancerous cell proliferation and induce their destruction. Dosage and frequency are determined by your oncologist based on your condition and may vary. Strict adherence to prescribed instructions is vital; misuse can lead to severe adverse reactions. Therapeutic effects might not be immediately apparent, requiring several weeks or months. Discontinue use only under medical guidance. Common side effects include anemia, leukopenia, increased bleeding risk, anorexia, nausea, and vomiting. Report any concerning symptoms to your doctor; management strategies exist. Prior to treatment, disclose any pre-existing blood, kidney, liver, or respiratory ailments. Mitodus can suppress blood cell production, elevating infection risk; regular blood tests monitoring blood counts, renal, hepatic, and cardiac function are mandatory. Effective contraception is crucial for both partners throughout treatment to prevent conception.
Uses of Mitodus 10mg Injection
Malignancies of the pancreas, breast, lung (non-small cell), and stomach.
Major Benefits of Mitodus 10mg Injection:
The medication will be administered by your physician or their designated nurse; please refrain from self-medicating.
Common Side effects of Mitodus 10mg Injection:
- Anemia (low number of red blood cells)
- Decreased white blood cell count
- Increased bleeding tendency
- Loss of appetite
- Nausea
- Vomiting
- Feeling of discomfort
- Low blood platelets
- Weight loss
- Rash
How to use Mitodus 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mitodus 10mg Injection works:
Oncolytic injection Mitodus, 10mg dose, targets cancer cells. Its mechanism involves DNA disruption within these cells, thereby halting their proliferation and growth.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Mitodus 10mg Injection and alcohol may result in increased sleepiness.
PregnancyUNSAFE
Administering Mitodus 10mg Injection to pregnant individuals carries a substantial risk. Pregnant women should consult their physician before use, as research involving animals and pregnant humans indicates considerable potential harm to the fetus.
Breast feedingCAUTION
Administering Mitodus 10mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Mitodus 10mg Injection might induce adverse reactions that compromise driving aptitude. Nausea and vomiting, potential side effects of Mitodus 10mg Injection, can significantly slow reflexes, hindering safe operation of a motor vehicle.
KidneyCAUTION
Exercise caution when administering Mitodus 10mg Injection to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Mitodus 10mg Injection is contraindicated in patients exhibiting end-stage renal disease.
LiverCAUTION
Exercise caution when administering Mitodus 10mg Injection to individuals with hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Mitodus 10mg Injection might be contraindicated in certain patients exhibiting liver dysfunction.
What if you forget to take Mitodus 10mg Injection :
NA
Facts to Know About Mitodus 10mg Injection
| Label | Value |
|---|---|
| Chemical Type | Cancer-Fighting Antibiotics |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Actions | Cytotoxic alkaloids |
